TCS partners with QIAGEN in driving its Cloud Transformation strategy

16 Jun 2022 , 02:38 PM

Tata Consultancy Services (TCS) has been selected by QIAGEN, a leading global provider of Sample to Insights solutions in life sciences and molecular diagnostics, as the strategic partner forits cloud transformation journey.

QIAGEN is investing in an ambitious cloud transformation to address new challenges of the post-pandemic era. It partnered with TCS for its deep contextual knowledge of the company’s infrastructure, applications, and systems, vast experience in the life sciences industry as well as its proven technology expertise. TCS will migrate the company’s workloads from its legacy data center to Microsoft Azure and build a new scalable digital core as a foundation forbetterways of working.

TCS’ team of cloud solution experts will work closely with QIAGENto design, implement and manage a cloud-first model. The new digital core will help improve internal and external collaboration, enabling greater innovation, and enhanced customer experience. Additionally, it will improve operational agility and resilience, drive efficiency,reduce QIAGEN’s carbon footprint and support its journey to net zero.

“QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth. A strong digital core will help QIAGEN to deliver innovation in a faster, more cost-efficient and secure way.

TCS has been a valuable strategic partner on this journey so far who will help us succeed in this cloud transformation,” said Josefine Danneberg, Senior Director, Head of Cloud Center of Excellence, QIAGEN.

“QIAGEN is a valued TCS customer, and we are thrilled to enter into this partnership to implement and manage their cloud strategy with Azureas the hyperscaler.

The new digital core will support better business outcomes, greater sustainability, and drive innovation forQIAGEN’s customers in life sciences and molecular diagnostics. We look forward to working alongside QIAGEN to support the company in achieving its vision of ‘making improvements in life possible’,” said Vikas Jain, Global Head, Life Sciences and Healthcare, Enterprise Growth Group, TCS.

At around 2:42 PM, TCS was trading at Rs3,136.60 per share down by Rs70.2 or 2.19% from its previous closing of Rs3,206.80 per share on the BSE.